• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.29%

    Seattle Genetics Inc. (SGEN)

    -NasdaqGS
    33.02 0.72(2.23%) Jan 26, 4:00PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.4
    Mean Recommendation (last week):2.4
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:46.00
    Median Target:45.00
    High Target:65.00
    Low Target:34.00
    No. of Brokers:13

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jul 9, 2014UBSUpgradeNeutralBuy
    Feb 13, 2013NeedhamDowngradeBuyHold
    Nov 8, 2012Cantor FitzgeraldDowngradeHoldSell
    Sep 7, 2012OppenheimerDowngradeOutperformPerform
    Aug 21, 2012Cantor FitzgeraldInitiated Buy
    Nov 11, 2011NeedhamInitiated Buy
    Oct 5, 2011Summer Street ResearchInitiated Sell
    Mar 9, 2011BioLogic Equity ResearchInitiated Sell
    Nov 2, 2010Canaccord GenuityDowngradeBuySell
    Nov 1, 2010Brean MurrayDowngradeHoldSell

    More Upgrades & Downgrades for SGEN

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy3333
    Buy5555
    Hold6664
    Underperform2223
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.